Publicaciones (37) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. Amino functionalized micro-mesoporous hybrid particles for the sustained release of the antiretroviral drug tenofovir

    Materials, Vol. 13, Núm. 16

  2. Antifungal and antiparasitic drug delivery

    Pharmaceutics, Vol. 12, Núm. 4

  3. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer

    International Journal of Pharmaceutics, Vol. 574

  4. Carrageenan-based acyclovir mucoadhesive vaginal tablets for prevention of genital herpes

    Marine Drugs, Vol. 18, Núm. 5

  5. Carrageenan: Drug Delivery Systems and Other Biomedical Applications

    Marine drugs, Vol. 18, Núm. 11

  6. Controlled release of highly hydrophilic drugs from novel poly(Magnesium acrylate) matrix tablets

    Pharmaceutics, Vol. 12, Núm. 2

  7. Current situation of carboplatin desensitisation protocols in the hospitals of Spain

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 6, pp. 369-370

  8. Design, fabrication and characterisation of drug-loaded vaginal films: State-of-the-art

    Journal of Controlled Release, Vol. 327, pp. 477-499

  9. Development and In Vitro/Ex Vivo Characterization of Vaginal Mucoadhesive Bilayer Films Based on Ethylcellulose and Biopolymers for Vaginal Sustained Release of Tenofovir

    Biomacromolecules, Vol. 21, Núm. 6, pp. 2309-2319

  10. Development of a solid formulation containing a microemulsion of a novel artemisia extract with nematocidal activity for oral administration

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-15

  11. Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction

    Chirality, Vol. 32, Núm. 2, pp. 185-190

  12. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 246-258

  13. Evaluating the potential of ursolic acid as bioproduct for cutaneous and visceral leishmaniasis

    Molecules, Vol. 25, Núm. 6

  14. Experimental evidence of harmful effects of Crithidia mellificae and Lotmaria passim on honey bees

    International Journal for Parasitology, Vol. 50, Núm. 13, pp. 1117-1124

  15. Flunarizine-loaded microparticles for the prophylaxis of migraine

    Journal of Drug Delivery Science and Technology, Vol. 60

  16. Gelatin nanoparticles-HPMC hybrid system for effective ocular topical administration of antihypertensive agents

    Pharmaceutics, Vol. 12, Núm. 4

  17. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

    International Journal of Pharmaceutics, Vol. 581

  18. Human Health Effects of Lactose Consumption as a Food and Drug Ingredient

    Current pharmaceutical design, Vol. 26, Núm. 16, pp. 1778-1789

  19. Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations

    Colloids and Surfaces B: Biointerfaces, Vol. 193

  20. Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses

    Scientific Reports, Vol. 10, Núm. 1